Each week we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing…
Each week we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing…
NEW YORK (Reuters Health) – Insulin degludec, an ultra-long-acting basal insulin, provides glycemic control in type 1 diabetes similar to that of insulin glargine but with lower occurrence…
NEW YORK (Reuters Health) – The combination of fibrate and statin therapy is a safe and efficacious treatment option for women with multiple lipid abnormalities, a multicenter team…
NEW YORK (Reuters Health) – The selective sinoatrial I-f current inhibitor ivabradine lowers heart rate in patients with stable coronary artery disease and impaired left ventricular systolic function…
NEW YORK (Reuters Health) – Warfarin dosing based on genotype-stratified tables is more accurate than empiric dosing, but not as good as estimates derived from formal pharmacogenetic algorithms,…
NEW YORK (Reuters Health) – A high loading dose of clopidogrel — 600 mg — appears to be unnecessary in Asian patients with ST-segment elevation myocardial infarction (STEMI)…
NEW YORK (Reuters Health) – The clinical efficacy of rituximab in rheumatoid arthritis (RA) depends on the degree of B cell depletion rather than the dose of rituximab,…
NEW YORK (Reuters Health) – The response rate to high-dose pulsed intravenous glucocorticoid therapy is about 80% for patients with active Graves’ orbitopathy, German clinicians report. However, they…
NEW YORK (Reuters Health) – Results of a large randomized, double-blind study suggest that the TNF inhibitor etanercept (Enbrel; Pfizer) may be more efficacious than sulfasalazine in the…
NEW YORK (Reuters Health) – In patients with chronic kidney disease (CKD), an impaired platelet response clopidogrel independently contributes to worse outcomes after percutaneous coronary intervention (PCI), a…
NEW YORK (Reuters Health) – Sumatriptan given subcutaneously relieves cyclic vomiting syndrome associated with migraine, researchers from Japan report in the December 8th online Cephalalgia. “Try sumatriptan for…
